We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Share Name | Share Symbol | Market | Type | Share ISIN | Share Description |
---|---|---|---|---|---|
Rm2 International S.a. | LSE:RM2 | London | Ordinary Share | LU1914372336 | ORD USD0.01 (DI) |
Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
---|---|---|---|---|---|---|---|---|---|---|
0.00 | 0.00% | 8.50 | - | 0.00 | 01:00:00 |
Industry Sector | Turnover | Profit | EPS - Basic | PE Ratio | Market Cap |
---|---|---|---|---|---|
0 | 0 | N/A | 0 |
Date | Subject | Author | Discuss |
---|---|---|---|
28/12/2016 16:16 | The market is telling us this is going up | nw99 | |
28/12/2016 16:07 | The pallet tracking device could be very valuable. | hibberts | |
28/12/2016 14:40 | Will Blue Prism Group plc be the next ARM Holdings after today’s profit upgrades? Image: Public domain Peter Stephens | Monday, 21st November, 2016 | More on: MCROPRSM 0 inShare Robotic process automation (RPA) specialist Blue Prism (LSE: PRSM) has released an excellent trading update today. It shows that the company expects to report financial performance for the year to 31 October which is comfortably ahead of previous expectations. As a result, its shares have risen by over 10% today. Could it become a major UK technology company, thereby becoming the next ARM Holdings? Blue Prism’s momentum in the first three quarters of the year continued into the final quarter. It achieved strong new business wins, with 39 customers won in the fourth quarter of the year. This takes its total customer base to 153 versus 57 at the same point last year. Blue Prism has been successful at upselling products and services to existing customers, while its channel partner ecosystem has continued to gain traction. Blue Prism has brought forward investments that were previously scheduled for 2017 into the second half of 2016. Alongside greater investment in growing its US sales team, this provides it with a bright long-term outlook. In fact, the RPA market continues to demonstrate encouraging signs of rapid growth. With Blue Prism having a sound balance sheet with £11.8m of net cash, it’s in a strong position to capitalise on long-term growth trends. | rubberbullets | |
28/12/2016 14:29 | Afraid montyhedge has no idea | nw99 | |
28/12/2016 12:30 | Wooden pallets rule. | montyhedge | |
28/12/2016 10:21 | Anyone accumulating below 40p will be doing a whole lot better than the 2015 fundraising and anyone in below £1 a whole lot better than Woodford stake. | my retirement fund | |
28/12/2016 08:11 | 40p is my first target .. | nw99 | |
23/12/2016 13:16 | WHERES COCO THE CLOWN, YOU KNOW, MY RETIREMENT FUND? tell them about yourself, coco, im sure it would be interesting. lol if only they knew, eh? | captain hindsight | |
23/12/2016 10:06 | They mentioned in a previous RNS that they had a deal awaiting signature agreement for £1m pm. I would like clarification if this has been signed. That, coupled with a solid manufacturing process would be truly transformative. Always difficult to value a company like this - by this time next year they could be making 4m pallets per year. Profit on those sold should be about $20 - but they also want to create a pallet pool - from memory the cost of production is about $50 (may be less if made in China/Mexico). To build up a large pool is going to take considerable finance. Perhaps thats where the non execs can prove their worth. Either way, its an interesting year ahead. In the two months I have had them I have already been about 20% up and 20% down... | dr biotech | |
23/12/2016 10:01 | 392,000 traded by 10am wow impressive buying | nw99 | |
23/12/2016 08:53 | Lets raise a glass to 2017 then. Woodford et al. aside, there certainly are a lot of people with a lot of skin in the game who would like to see this all come good who are either connected parties or are sitting on the board here. That's for sure ! | my retirement fund | |
23/12/2016 08:48 | Picked up a few more this am | nw99 | |
23/12/2016 07:08 | A good article mentions RM2 and Neil Woodford today . Saying 2017 is when it all happens in the Times | nw99 | |
22/12/2016 16:43 | Dr Bio , as I have always thought this is a long term trade but given the stock came down so low this is an absolute bargain . | nw99 | |
22/12/2016 16:31 | Well if they have orders for a year and their manufacturing sorted then it could be a very different company this time next year? What could possibly go wrong? Probably best not to think about that. | dr biotech | |
22/12/2016 13:14 | Added nicely this am | nw99 | |
22/12/2016 08:00 | Looks like Chinese production will slightly delayed early Q2 rather than Q1. Hopefully reliable production leads to more sales. Margin seems to be about $20 per pallet over time. Potential is enormous | dr biotech | |
22/12/2016 07:59 | Just have to hope Trump doesn't kibosh it... | phowdo | |
22/12/2016 07:21 | Good news time to add this am looks like 2017 will be the time for RM2 | nw99 | |
07/12/2016 10:05 | Buying this retrace | nw99 |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions